BW
COCH icon

Boaz Weinstein’s Envoy Medical COCH Stock Holding History

Boaz Weinstein’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,358,792
Closed -$13.6M – 772
2022
Q4 		$13.6M Hold
1,358,792
– – 0.18% 176
2022
Q3 		$13.3M Buy
1,358,792
+125,000
+10% +$1.23M 0.15% 235
2022
Q2 		$12.1M Buy
1,233,792
+161,000
+15% +$1.58M 0.14% 249
2022
Q1 		$10.5M Buy
1,072,792
+19,304
+2% +$188K 0.15% 221
2021
Q4 		$10.3M Buy
1,053,488
+100,901
+11% +$984K 0.16% 178
2021
Q3 		$9.24M Buy
952,587
+2,587
+0.3% +$25K 0.23% 106
2021
Q2 		$9.21M Buy
+950,000
New +$9.23M 0.26% 76

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Boaz Weinstein's COCH Position: Q1 2023 in Review

Boaz Weinstein sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 1,358,792 shares — an estimated $13.6M sold.

Boaz Weinstein first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $13.6M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Boaz Weinstein reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Boaz Weinstein sold 1,358,792 Envoy Medical shares in Q1 2023, an estimated $13.6M.
  • Boaz Weinstein first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Boaz Weinstein's Envoy Medical position peaked at $13.6M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Saba Capital Management's 13F filing for Q1 2023, filed 15 May 2023.